Fig 2.
Effects of IL-2 CLDC treatment on neutrophil and monocyte counts. Six healthy, 6–8-month-old purpose-bred cats were randomized into two treatment groups of three cats each (group 1). One subgroup of three cats was injected intraperitoneally once weekly with 150 μg IL-2 CLDC (IL-2 CLDC). A second subgroup of three cats was injected intraperitoneally with saline only (control). Neutrophil (reference range 2–12.0×103/μl) and monocyte (reference range 0.0–0.8×103/μl) counts were determined for each group of animals and the mean (±SD) was plotted. (A) Neutrophil (‘PMN’) counts were significantly increased (P<0.05) in cats treated with IL-2 CLDC, beginning within 24 h of the first injection. (B) Monocyte (‘Monos‘) counts were significantly increased (P<0.05) by the first week after treatment.